Background: HIV assays designed to detect recent infection, also known as “recency
assays,” are often used to estimate HIV incidence in a specific country, region, or …

Introduction The need for detection of new and recent HIV infections is essential for
surveillance and assessing interventions in controlling the epidemic. HIV recency assays …

Background Recent infection testing algorithms (RITAs) incorporating clinical information
with the HIV recency assay have been proven to accurately classify recent infection …

The plan for Ending the HIV (human immunodeficiency virus) Epidemic (EHE) in the United
States aims to reduce new infections by 75% by 2025 and by 90% by 2030. For EHE to be …

Monitoring genetic diversity and recent HIV infections (RHIs) is critical for understanding HIV
epidemiology. Here, we report HIV-1 genetic diversity and RHIs in blood samples from 190 …

Serological methods to differentiate between recently acquired and established HIV-1
infections are a useful tool in the HIV-surveillance to characterize the epidemic, identify …

Background Early diagnosis is crucial in securing optimal outcomes in the HIV care
cascade. Recent HIV infection (RHI) serves as an indicator of early detection in the course of …

Abstract Introduction The HPTN 071 (PopART) trial evaluated the impact of an HIV
combination prevention package that included “universal testing and treatment” on HIV …

Laboratory assays for identifying recent HIV-1 infections are widely used for estimating
incidence in cross-sectional population-level surveys in global HIV-1surveillance. Adequate …

Recency assays use one or more biomarkers to identify whether HIV infection in a person is
recent (usually within a year or less) or longstanding. Recency assays have been used to …